Lipitor Product Launch
Lipitor-X Product Launch Plan
Pfizer Inc is the largest research based biomedical and pharmaceutical company in the world. Headquartered in New York, Pfizer has major research and development locations in England and the United States. Since its inception in 1849, the organization has remained dedicated to discovering and developing new and better ways to prevent and treat disease, while helping to improve health and well being for people around the world. In November, the Pfizer product Lipitor that is currently taken by over 4.3 million Americans and accounts for over $10.8 billion in annual sales that represents about 15.8% of the organization’s total revenue will go off-patent after the American Patent Office rejection of the company’s calcium salt re-issue application. Therefore, with the product set to be offered in generic form by several long-time competitors, the organization reviewed strategies to accelerate and refocus Pfizer’s pipeline and capture new opportunities for global growth in the Peoples Republic of China (PRC) to keep the financial pipeline flowing with this drug that would be renamed “Lipitor-X” and distributed to the Chinese public as an over-the-counter (OTC) offering (Pfizer, 2011). The second phase of the Pfizer strategy to enter the Asian market is the proposed expansion into the Republic of Vietnam The product is identified as Lipitor-X. It is a drug made up of atorvastatin, which is clinically proven to reduce bad cholesterol levels and improve a person’s physical health along with diet and exercise. Lipitor-X will act as a reductase inhibitor, which is a drug that works by basically loosening the fat and cholesterol that is clogging the arteries (US National Library of Medicine, 2010). As Lipitor-X cleans out a person’s arteries, the blood will flow more freely through the body and the risk of stroke or heart disease will be reduced significantly. Lipitor-X will be manufactured and distributed in China and
Pfizer Inc is the largest research based biomedical and pharmaceutical company in the world. Headquartered in New York, Pfizer has major research and development locations in England and the United States. Since its inception in 1849, the organization has remained dedicated to discovering and developing new and better ways to prevent and treat disease, while helping to improve health and well being for people around the world. In November, the Pfizer product Lipitor that is currently taken by over 4.3 million Americans and accounts for over $10.8 billion in annual sales that represents about 15.8% of the organization’s total revenue will go off-patent after the American Patent Office rejection of the company’s calcium salt re-issue application. Therefore, with the product set to be offered in generic form by several long-time competitors, the organization reviewed strategies to accelerate and refocus Pfizer’s pipeline and capture new opportunities for global growth in the Peoples Republic of China (PRC) to keep the financial pipeline flowing with this drug that would be renamed “Lipitor-X” and distributed to the Chinese public as an over-the-counter (OTC) offering (Pfizer, 2011). The second phase of the Pfizer strategy to enter the Asian market is the proposed expansion into the Republic of Vietnam The product is identified as Lipitor-X. It is a drug made up of atorvastatin, which is clinically proven to reduce bad cholesterol levels and improve a person’s physical health along with diet and exercise. Lipitor-X will act as a reductase inhibitor, which is a drug that works by basically loosening the fat and cholesterol that is clogging the arteries (US National Library of Medicine, 2010). As Lipitor-X cleans out a person’s arteries, the blood will flow more freely through the body and the risk of stroke or heart disease will be reduced significantly. Lipitor-X will be manufactured and distributed in China and
References: China 's population. The most surprising demographics . (2011). Retrieved from http://www Gullo, K. 2011. “Pfizer, Ranbaxy Sued Over Lipitor Prices by 11 Pharmacies.” Bloomberg. NetMBA, Business Knowledge Center (2011). Market Definition. Retrieved November 11, 2011 from http://www.netmba.com/marketing/market/definition/ Pfizer, (2011) US National Library of Medicine. 2010. “Atorvastatin.” AHFS Consumer Medication Information. Kotler, P., & Keller, K. L. (2007). Designing and Managing Integrated Marketing Communications. In A Framework for Marketing Management. Upper Saddle River, New Jersey: Pearson PrentHall. The 2012 Statistical Abstract - U.S. Census Bureau. (2011). Retrieved from http://www.census.gov/compendia/statab/Cached New York Times Pacific Health Summit. (2007, October). Responding to the Modern Lifestyle: A Personal Approach to Health Using Chinese Medical Science. Retrieved from http://pacificsummit.org Stonehouse, G., Campbell, D., Hamil, J., & Purdie, T Buckley, C. (2011, November 27). Global Economic Outlook Grim, China Tells U.S. Trade. Retrieved from http://www.reuters.com/article/2011/11/21 ComputerTalk for the Pharmacist (2011) November 27, 2011 from http://www.computertalk.com/content/view/606/187/ Currency Calculations (2011) Doing Business in Vietnam: 2011 Country Commercial Guide for U.S. Companies (2011, November). Retrieved from http://export.gov/Vietnam/build/groups Dow Jones (2004) eNotes (2011). Pharmacy in China. Retrieved November 27, 2011 from http://www.enotes.com/topic/Pharmacy_in_China Find best drug prices (2011) Gatyas, Gary (2011). “IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion.” IMS Health Kotler, P., & Keller, K Nguyen, Vinh (2008). Vietnam Pharmaceutical Industry-Investment Strategy. Vietnam Department of Pharmaceutical Management PharmAssist Innovation (2011) PharmPro (2011). Pharmaceutical Costs, Technology Innovation and Opportunities. Retrieved November 27, 2011 from http://www.pharmpro.com/articles/2010/03/business-Pharmaceutical-Costs-Technology-Innovation-Opportunities-and-Reality/ The Impact of Monetary Policy and Fiscal Policy on the Exchange Rate (2011, November) Retrieved from http://www.chinafinancialdaily.com The Peoples Republic of China (2011, November 27) Western Journal of Medicine (2011). An Introduction to Cultural Differences. Retrieved November 27, 2011 from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1070887/ World Bank (2010) Digital Trends (2011). If Facebook Enters China, How Will it Compete. Retrieved December 5, 2011 from http://www.digitaltrends.com/international/if-facebook-reenters-china-how- Retrieved December 5, 2011 from http://www.ernestjwilson.com/uploads/TRENDS.PDF USC School of Communication and Journalism (2011) December 5, 2011 from http://ascportfolios.org/chinaandmedia/2011/01/16/3-top- chinese-tech-trends-for-2011social-networks-localized-services-and-price-reductions/ Kotler, P., & Keller, K. L. (2007). Designing and Managing Integrated Marketing Communications. In A Framework for Marketing Management (pp. 278-293). Upper Saddle River, New Jersey: Pearson Prentice Hall. Internet World Stats. Usage and Population Statistics. (2011). Retrieved from http://www.internetworld stats.com/asia/ch/vn.htm. Cateora, P., & Graham, J. (2007). International Marketing (13th ed.). New York, NY: McGraw Hill Companies Inc. Materi, Romana. (2004). Interim Report: A Case Study of Internet-Based Advertising in Vietnam. Athabasca University, Canada.